| Pancreatic adverse events in patients treated with immune checkpoint inhibitors C Hana, T Rehman, K Park, C Carracedo Uribe, PP Aung, B Hunis, ... JGH Open 7 (3), 204-207, 2023 | 6 | 2023 |
| EGFR L718V (+)/T790M (–) as a Mechanism of Resistance in Patients with Metastatic Non–small-cell Lung Cancer with EGFR L858R Mutations LE Raez, C Carracedo, LM Drusbosky, M Velez, J Carlisle, ... Clinical Lung Cancer 22 (6), e817-e819, 2021 | 6 | 2021 |
| Mortality and prognostic factors in hospitalized COVID-19 patients with cancer: an analysis from a large healthcare system in the United States LE Raez, M Tarockoff, CRC Uribe, J Niu, C Sareli, N Sundararaman, J Ion, ... Annals of Translational Medicine 10 (20), 2022 | 4 | 2022 |
| Bruton’s Tyrosine Kinase Inhibitors: Recent Updates A Fares, C Carracedo Uribe, D Martinez, T Rehman, C Silva Rondon, ... International Journal of Molecular Sciences 25 (4), 2208, 2024 | 2 | 2024 |
| Importance of ROS1 gene fusions in non-small cell lung cancer M Muminovic, CRC Uribe, A Alvarez-Pinzon, K Shan, LE Raez Cancer Drug Resistance 6 (2), 332, 2023 | 2 | 2023 |
| Diversity and Disparities in Lung Cancer Outcomes Among Minorities NWY Theik, CC Uribe, A Alvarez, M Muminovic, LE Raez The Cancer Journal 29 (6), 323-327, 2023 | 1 | 2023 |
| Acquired EGFR-resistant mutations in non–small cell lung cancer (NSCLC) LE Raez, Y Baca, JJ Nieva, H Mamdani, G Lopes, H Borghaei, ... J. Clin. Oncol 40 (9113), 10.1200, 2022 | 1 | 2022 |
| Outcomes with bevacizumab for radiation induced-brain necrosis. M Muminovic, CC Uribe, S Dalal, I Castellon, A Falchook, O Nano, ... Journal of Clinical Oncology 41 (16_suppl), e14006-e14006, 2023 | | 2023 |
| Mortality and prognostic factors in hospitalized COVID-19 patients with cancer: An analysis from a large healthcare system in the United States. M Tarockoff, LE Raez, CC Uribe, J Niu, C Sareli, N Sundararaman, J Ion, ... Journal of Clinical Oncology 40 (16_suppl), e24063-e24063, 2022 | | 2022 |
| Evaluation of tumor gene expression profile (GEP) in minority patients with stage IV non-small cell lung cancer (NSCLC). M Villanueva, CC Uribe, K Brice, K Dumais, O Nano, M Rodriguez, ... Journal of Clinical Oncology 40 (16_suppl), e21043-e21043, 2022 | | 2022 |
| Hospital Mortality and Length of Stay for Patients with Myelodysplastic Syndrome Presenting with Acute ST-Elevation Myocardial Infarction (STEMI) K Park, PP Aung, CU Carlos, K Himed, J Yu, J Jacob Blood 138, 4674, 2021 | | 2021 |
